Rating Change
B. Riley Securities analysts initiated coverage on Lyell Immunopharma, Inc. (NASDAQ:LYEL) with a Buy rating on July 22, 2026.
Rating Change B. Riley Securities analysts initiated coverage on Lyell Immunopharma, Inc. (NASDAQ:LYEL) with a Buy rating on July 22, 2026.

B. Riley Securities analysts initiated coverage on Lyell Immunopharma, Inc. (NASDAQ:LYEL) with a Buy rating on July 22, 2026.
Lyell Immunopharma, Inc. operates in the Healthcare sector. The stock currently trades at $12.92 with a market capitalization of $708.0M. The stock has gained 35.7% over the past 52 weeks.
Analyst coverage from B. Riley Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Lyell Immunopharma, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 22, 2026 | B. Riley Securities | Buy | N/A |
| Jun 15, 2026 | Citizens | Market Outperform | N/A |
| Jun 15, 2026 | Needham | Buy | N/A |
| Jun 09, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 08, 2026 | Needham | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View LYEL Stock Page
A Buy rating from B. Riley Securities reflects the analyst's outlook on Lyell Immunopharma, Inc. (NASDAQ:LYEL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the LYEL forecast page.
Current market data
NASDAQ · LYEL
$15.53
Up: +$0.18 · +1.17%
Live quote updated
Keep reading
earnings ·
earnings ·
price ·
sec_filing ·